Home

Windlas Biotech Ltd Quarterly Result

Image

Windlas Biotech Ltd

NSE: WINDLAS

Net Profit - Last Quarter

₹ 15.66 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Windlas Biotech Ltd for the Sep '24 is ₹ 191.84 crore as compare to the Jun '24 revenue of ₹ 179.29 crore. This represent the growth of 6.999834%.
  • The ebitda of Windlas Biotech Ltd for the Sep '24 is ₹ 27.89 crore as compare to the Jun '24 ebitda of ₹ 25.01 crore. This represent the growth of 11.51539%.
  • The net profit of Windlas Biotech Ltd for the Sep '24 is ₹ 15.66 crore as compare to the Jun '24 net profit of ₹ 13.48 crore. This represent the growth of 16.17211%.

Results Analysis

Market Price of Windlas Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Windlas Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251005.45
14 Jan 2025986.65
13 Jan 2025924.45
10 Jan 2025988.15
09 Jan 20251015.25
08 Jan 20251061.65
07 Jan 20251028.55
06 Jan 20251003.15
03 Jan 20251008.3
02 Jan 20251023.5

Historical Revenue of Windlas Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Windlas Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Windlas Biotech Ltd

No data available

* All values are in crore

Windlas Biotech Ltd News Hub

Windlas Biotech consolidated net profit rises 11.68% in the June 2024 quarter

Net profit of Windlas Biotech rose 11.68% to Rs 13.48 crore in the quarter ended June 2024 as agains

Read more

13 Aug 2024

Windlas Biotech to declare Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024. Powe

Read more

03 Aug 2024

Windlas Biotech schedules AGM

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be held on 24 Se

Read more

03 Sep 2024

Windlas Biotech to hold AGM

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be held on 24 Se

Read more

03 Sep 2024

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Windlas Biotech Ltd

What key financial metrics are included in Windlas Biotech Ltd's quarterly results?

Key financial metrics in Windlas Biotech Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Windlas Biotech Ltd announce its quarterly results?

Windlas Biotech Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Windlas Biotech Ltd's quarterly performance impact its stock price?

Windlas Biotech Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Windlas Biotech Ltd's quarterly results on dividends?

The impact of Windlas Biotech Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Windlas Biotech Ltd's quarterly results?

Yes, Windlas Biotech Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions